Micrus Endovascular (MEND) Posts Q3 EPS of $0.22, Tops Street Views
More News related to MEND
- Micrus Endovascular to Present at the Piper Jaffray 21st Annual Health Care Conference
- Susquehanna Maintains a 'Positive' Rating on Micrus Endovascular (MEND); Long-Term Story Remains Intact
- Morning Movers 11/05: ROYL, RX, FSYS, KAI, SANM Higher; SMSI, CVS, MBRK, INOD, PL, ARO Lower
- Micrus Endovascular (MEND) Posts Q3 EPS of $0.22, Tops Street Views
- Micrus Endovascular Reports Fiscal Second Quarter Revenues of $21.5 Million and Diluted EPS of $0.22
Micrus Endovascular (NASDAQ: MEND) reports Q3 EPS of $0.22, versus the analyst estimate of $0.05. Revenue for the quarter was $21.50 million, which compares to the estimate of $20.46 million.
Related Categories
EarningsStocks Mentioned
-0.43Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
